Thiotepa Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-446

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Thiotepa (NDC 68083-446). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Thiotepa Spl Carton 100 mg

Packaging label for Thiotepa for Injection, USP 100 mg/vial by Gland Pharma Limited. The lyophilized powder for solution is for intravenous, intracavitary, or intravesical use. Label includes storage instructions to refrigerate between 2°C to 8°C, caution indicating it is a cytotoxic agent, and directions for single dose vial and discard of unused portion. The label also shows the NDC 68083-503-01 and manufacturing location in Visakhapatnam, India.*

FDA Label Image

Thiotepa Spl Carton 15 mg

Packaging label for Thiotepa for Injection, USP, 15 mg/vial, a lyophilized powder for solution. The label indicates use for intravenous, intracavitary, or intravesical administration and includes warnings about refrigerated storage, single-dose vial use, and cytotoxic agent caution. Manufactured by Gland Pharma Limited, India, the label also includes handling and dosage instructions along with a barcode.*

FDA Label Image

Thiotepa Spl Container 100 mg

Label for Thiotepa for Injection, USP 100 mg/vial, a cytotoxic agent for intravenous, intracavitary, or intravesical use. This single dose vial is labeled by Gland Pharma Limited, with storage and usage instructions advising to discard unused portions and read package leaflet for dosage and prescribing information.*

FDA Label Image

Thiotepa Spl Container 15 mg

Thiotepa for Injection, USP 15 mg/vial label for a single dose vial intended for intravenous, intracavitary, or intravesical use. The label highlights the product as a cytotoxic agent and includes the labeler name Gland Pharma Limited, with instructions to discard unused portions. The NDC 68083-446-01 is visible alongside a barcode and spaces for lot number and expiration date.*

FDA Label Image

Thiotepa-spl-structure (Thiotepa Spl Structure)

Chemical structure of Thiotepa, a pharmaceutical active ingredient. The diagram shows the molecular configuration including phosphorus (P), sulfur (S), nitrogen (N), and three aziridine rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.